5-hydroxydecanoate has been researched along with Chronic Disease in 2 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neckár, J | 1 |
| Szárszoi, O | 1 |
| Koten, L | 1 |
| Papousek, F | 1 |
| Ost'ádal, B | 1 |
| Grover, GJ | 1 |
| Kolár, F | 1 |
| Eells, JT | 1 |
| Henry, MM | 1 |
| Gross, GJ | 1 |
| Baker, JE | 1 |
2 other studies available for 5-hydroxydecanoate and Chronic Disease
| Article | Year |
|---|---|
Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats.
Topics: Altitude; Analysis of Variance; Animals; Benzopyrans; Chronic Disease; Decanoic Acids; Diazoxide; Hy | 2002 |
Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics?
Topics: Adaptation, Physiological; Adenosine Triphosphate; Animals; Animals, Newborn; Benzopyrans; Cell Hypo | 2000 |